tetrabenazine has been researched along with DiGeorge Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bassett, AS; Boot, E; Butcher, NJ; Chow, EWC; Christopher, L; Fritsch, R; Lang, AE; Marras, C; Masellis, M; Pondal, M; Repetto, GM; Rusjan, P; Strafella, AP | 1 |
| Barrett, MJ; Bassett, AS; Berman, BD; Booij, J; Boot, E; Borg, M; Bourdain, F; Butcher, NJ; Charles, P; Clerinx, K; Colin, O; Danaila, T; Drapier, S; Dufournet, B; Fiksinski, AM; Gasser, T; Jacquette, A; Kaneko, S; Lang, AE; Marras, C; Masellis, M; Mills, K; Mok, KY; Mutez, E; Nguyen, K; Perandones, C; Plate, A; Prontera, P; Swillen, A; Udow, S; Vergaelen, E; Vogels, A; Williams, NM; Wood, NW | 1 |
2 other study(ies) available for tetrabenazine and DiGeorge Syndrome
| Article | Year |
|---|---|
Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.
Topics: Adult; Carbon Radioisotopes; Case-Control Studies; Corpus Striatum; DiGeorge Syndrome; Female; Functional Neuroimaging; Humans; Hypertrophy; Male; Parkinson Disease, Secondary; Positron-Emission Tomography; Substantia Nigra; Tetrabenazine; Ultrasonography, Doppler, Transcranial | 2017 |
Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.
Topics: Adult; Antiparkinson Agents; Databases, Bibliographic; Deep Brain Stimulation; DiGeorge Syndrome; Female; Humans; International Cooperation; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Sex Distribution; Statistics, Nonparametric; Tetrabenazine; Tomography, Emission-Computed, Single-Photon | 2018 |